Fund moves

Biogen (BIIB): Primecap Management Co reduced its stake -847K shares

Primecap Management Co reduced its stake in Biogen, per its Q3 2025 13F.

15M
Shares reported · -847K vs prior quarter
1.6%
Disclosed portfolio weight
$2.09B
Reported value
Holdings as of
Sep 30, 2025
Filed
Nov 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 14, 2025Company filing · Form 8-K · ResultsReported its results
  2. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
  3. Nov 10, 20255% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.0%

What came next

  1. Jan 13, 2026Company filing · Form 8-K · ResultsReported its results
  2. Jan 30, 2026CongressDisclosed purchase of BIIB — reported range $1,001 - $15,000
  3. Feb 2, 2026InsiderOfficer sold ~$134K of BIIB shares in the open market
  4. Feb 5, 20265% stakeFMR LLC reported a passive stake (13G) of 6.4%
  5. Feb 6, 2026Company filing · Form 8-K · ResultsReported its results
  6. Feb 9, 2026InsiderOfficer sold ~$532K of BIIB shares in the open market
  7. Feb 11, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On February 11, 2026, Caroline Dorsa, Chair of the Biogen Inc. (“Biogen” or the “Company”) Board of Directors (the “Board”) announced that she would not stand for re-election to the Board at the 2026 Annual Meeting of Stockholders (the “Annual Meeting”).”
  8. Feb 12, 2026Insider · Their first buy on recordOfficer purchased ~$585 of BIIB shares in the open market
  9. Mar 11, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 11, 2026, Biogen Inc. (the “Company”) announced that Susan H. Alexander, Chief Legal Officer, will depart from the Company effective as of the end May, 2026.”
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Biogen

For Biogen, OQRO holds 2 Congress trade reports dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BIIB page.

How this filing works

Explore the data

Common questions

What does this filing report about Biogen (BIIB) stock?

Primecap Management Co reduced its stake in Biogen, per its Q3 2025 13F. Now 15M shares, $2.09B reported value, 1.6% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Sep 30, 2025. Filed: Nov 12, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Biogen recently?

For Biogen, OQRO holds 2 Congress trade reports dated in the last 90 days. They are listed on the BIIB page.

Does this mean BIIB stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Biogen

Everything OQRO holds on this company is on its BIIB page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data